Basic information Pharmacology Tolerability Safety Related Supplier
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Plant extracts >  Docetaxel trihydrate

Docetaxel trihydrate

Basic information Pharmacology Tolerability Safety Related Supplier
Docetaxel trihydrate Basic information
Docetaxel trihydrate Chemical Properties
  • Melting point:186-192°C
  • solubility Practically insoluble in water, freely soluble in anhydrous ethanol, soluble in methylene chloride.
  • form neat
  • InChIKeyXCDIRYDKECHIPE-KHDBCEGQSA-N
  • CAS DataBase Reference148408-66-6(CAS DataBase Reference)
Safety Information
  • WGK Germany 3
  • HS Code 2932996560
Docetaxel trihydrate Usage And Synthesis
  • Pharmacology

    Docetaxel principally exerts its cytotoxic activity by promoting and stabilising microtubule assembly while simultaneously preventing microtubule depolymerisation. This results in inhibition of normal cell division. In vitro and in vivo, docetaxel has antineoplastic activity against a wide range of cancer cells, demonstrates synergistic activity with several antineoplastic agents and often has greater cytotoxic activity against human breast cancer cell lines than paclitaxel. Docetaxel, binds to and stabilizes tubulin, which prevents physiological microtubule depolymerization/disassembly and results in cell-cycle arrest at the G2/M phase and cell death. This agent also is known to inhibit the anti-apoptotic gene Bcl2 and to encourage the expression of p27, a cell-cycle inhibitor, and further pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Docetaxel is mainly metabolized in the liver by the cytochrome P450 CYP3A4 and CYP3A5 subfamilies of isoenzymes, and its clearance has been shown to be related to body surface area and hepatic enzyme and alpha1 acid glycoprotein plasma levels.

  • Tolerability

    The tolerability of docetaxel in comparative clinical trials was generally acceptable. Severe neutropenia affects most docetaxel recipients, with febrile neutropenia occurring in approximately one-eighth of patients. Dose-cumulative severe fluid retention was reported in docetaxel recipients, despite premedication with prophylactic corticosteroids. Other adverse events include asthenia, stomatitis, infections, neurosensory, cutaneous or gastrointestinal events, nail changes, severe fever in the absence of infection, myalgia and hypersensitivity reactions.

  • Chemical PropertiesWhite Crystalline Powder
  • UsesAn antineoplastic. An antimitotic agent that promotes the assembly of microtublules and inhibits their depolymerization to free tubulin
  • DefinitionChEBI: The trihydrate form of docetaxel. It is used for the treatment of breast, ovarian, and non-small cell lung cancer, and with prednisone or prednisolone in hormone-refractory metastatic prostate cancer.
  • brand nameTaxotere (Sanofi Aventis).
Docetaxel trihydrate(148408-66-6)Related Product Information
Docetaxel trihydrateSupplierMore
  • Company Name:Beijing Yibai Biotechnology Co., Ltd. Gold
  • Tel:18811377237
  • Email:shadow@yibaibiotech.com
  •  
  • Company Name:Fujian South Pharmaceutical Co., Ltd. Gold
  • Tel:13509335186 0598-2860412
  • Email:sales@southpharma.com
  •  
  • Company Name:Hefei NaNo Biological Technology Co., Ltd. Gold
  • Tel:18010855303
  • Email:sales@hfnhsw.com;
  •  
  • Company Name:Jiangsu Yew Pharmaceutical Co., Ltd. Gold
  • Tel:18921335032 189-2133-5032
  • Email:tanchunhua@hongdou.com
  •  
  • Company Name:Guangzhou Tomums Life Science Co., Ltd. Gold
  • Tel:18927568969 020-31155029
  • Email:1352410245@qq.com
  •  
Related articles